Document Detail


Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
MedLine Citation:
PMID:  21381184     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The safety of selective serotonin reuptake inhibitors (SSRIs) during pregnancy remains uncertain. The purpose of this study was to investigate dispensing patterns and pregnancy outcomes for women dispensed an SSRI in pregnancy. METHODS: Using data linkage of population-based health datasets from Western Australia and a national pharmaceutical claims dataset, our study included 123,405 pregnancies from 2002 to 2005. There were 3764 children born to 3703 women who were dispensed an SSRI during their pregnancy. RESULTS: A total of 42.3% of the women were dispensed an SSRI in each trimester, and 97.6% of the women used the same SSRI throughout the first trimester without switching. The women who were dispensed an SSRI were more likely to give birth prematurely (adjusted odds ratio [aOR], 1.4; 95% confidence interval [CI], 1.2-1.7), to have smoked during the pregnancy (OR, 1.9; 95% CI, 1.8-2.1), and parity >1 (OR, 1.7; 95% CI, 1.5-1.8). The singletons were found to have a lower birth weight than expected when other factors were taken into account (OR, 1.2; 95% CI, 1.1-1.3). There was an increased risk of major cardiovascular defects (OR, 1.6; 95% CI, 1.1-2.3). The children of women dispensed citalopram during the first trimester had an increased risk of vesicoureteric reflux (OR, 3.1; 95% CI, 1.3-7.6). Children born to women dispensed sertraline had a higher mean birth weight than those born to women dispensed citalopram, paroxetine, or fluoxetine. This pattern was also seen in birth length. CONCLUSIONS: Most women were dispensed the same SSRI throughout their pregnancy. We have confirmed previous findings with an increased risk of cardiovascular defects and preterm birth. New findings requiring confirmation include an increased risk of vesicoureteric reflux with the use of citalopram. Birth Defects Research (Part A), 2011. © 2011 Wiley-Liss, Inc.
Authors:
Lyn Colvin; Linda Slack-Smith; Fiona J Stanley; Carol Bower
Related Documents :
10838124 - Uteroplacental circulatory disturbance mediated by prostaglandin f2alpha in rats expose...
15935854 - Hypoluteoidism in a bitch.
20911184 - The prognosis and treatment of eclampsia and albuminuria, with special reference to the...
7124294 - Circadian rhythm of serum progesterone levels in human pregnancy and its relation to th...
19485164 - Clinical rabies in pregnancy with delivery of a live fetus: a case report.
2378604 - Dexamethasone can prevent stress-related litter deficits in the golden hamster.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-4
Journal Detail:
Title:  Birth defects research. Part A, Clinical and molecular teratology     Volume:  -     ISSN:  1542-0760     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101155107     Medline TA:  Birth Defects Res A Clin Mol Teratol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Wiley-Liss, Inc.
Affiliation:
Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia,Perth, Western Australia, Australia; School of Dentistry, The University of Western Australia, Perth, Western Australia, Australia. lync@ichr.uwa.edu.au.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Odd-skipped maintains prohemocyte potency and blocks blood cell development in Drosophila.
Next Document:  Paper 6: EUROCAT member registries: Organization and activities.